Skip to main content
Deutsches Ärzteblatt International logoLink to Deutsches Ärzteblatt International
letter
. 2018 Feb 9;115(6):98. doi: 10.3238/arztebl.2018.0098a

Correspondence (letter to the editor): Additional Information

Helmut Kingreen *
PMCID: PMC5832896  PMID: 29478440

The occurrence of aluminum-induced encephalopathy in dialysis patients was first reported in the mid-1970s, based on case reports from Canada and the Netherlands. Significantly increased levels of aluminum in patient plasma were found to be caused by using aluminum-coated anodes for preheating raw water for use in dialysate production. It was not until later that the so-called reverse osmosis process was implemented for water treatment, after which aluminum intoxication in dialysis patients has only rarely occurred.

However, the authors of the article (1) must be corrected when they state that aluminum salts were added to "dialysate as a phosphate binder". Such a process is impossible in the preparation of dialysate, and it is also completely illogical, as aluminum salts inhibit enteral phosphate reabsorption.

References

Footnotes

Conflict of interest statement

The author declares that no conflict of interest exists..

References

  • 1.Klotz K, Weistenhöfer W, Neff F, Hartwig A, van Thriel C, Drexler H. The health effects of aluminum exposure. Arztebl Int. 2017;114:653–659. doi: 10.3238/arztebl.2017.0653. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Deutsches Ärzteblatt International are provided here courtesy of Deutscher Arzte-Verlag GmbH

RESOURCES